Dr. Michael Scordo, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Hematologic Malignancies
Studies Blood Cancers
5 reported clinical trials
12 drugs studied

Area of expertise

1Hematologic Malignancies
Michael Scordo, MD has run 2 trials for Hematologic Malignancies. Some of their research focus areas include:
Stage I
Stage II
Chromosome 7 abnormality positive
2Blood Cancers
Michael Scordo, MD has run 2 trials for Blood Cancers. Some of their research focus areas include:
Stage I
Stage II
Chromosome 7 abnormality positive

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center
Image of trial facility.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Michael Scordo, MD is currently running

More about Michael Scordo, MD

Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Scordo, MD has experience with
  • Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
  • Antithymocyte Globulin (ATG)
  • Busulfan
  • Fludarabine
  • Melphalan
  • Romiplostim

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Michael Scordo, MD specialize in?
Is Michael Scordo, MD currently recruiting for clinical trials?
Are there any treatments that Michael Scordo, MD has studied deeply?
What is the best way to schedule an appointment with Michael Scordo, MD?
What is the office address of Michael Scordo, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security